FDA launches external defibrillator improvement initiative

The Food and Drug Administration (FDA) recently announced an initiative to improve external defibrillators used to treat sudden cardiac arrest in hospitals and other settings. In the past five years, FDA's Center for Devices and Radiological Health has received more than 28,000 reports associated with the failure of external defibrillators.

Click here for more information.